235 related articles for article (PubMed ID: 16123742)
21. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny.
Swerdlow NR; Platten A; Hanlon FM; Martinez ZA; Printz MP; Auerbach P
Neuropsychopharmacology; 2003 Feb; 28(2):226-34. PubMed ID: 12589375
[TBL] [Abstract][Full Text] [Related]
22. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
24. Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z).
van den Buuse M; Martin S; Brosda J; Leck KJ; Matthaei KI; Hendry I
Psychopharmacology (Berl); 2005 Dec; 183(3):358-67. PubMed ID: 16220329
[TBL] [Abstract][Full Text] [Related]
25. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat?
Swerdlow NR; Varty GB; Geyer MA
Neuropsychopharmacology; 1998 Jan; 18(1):50-6. PubMed ID: 9408918
[TBL] [Abstract][Full Text] [Related]
26. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating.
Swerdlow NR; Breier M; Mora AB; Ko D; Shoemaker JM
Pharmacol Biochem Behav; 2008 Jan; 88(3):280-90. PubMed ID: 17936348
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains.
Swerdlow NR; Shoemaker JM; Crain S; Goins J; Onozuka K; Auerbach PP
Pharmacol Biochem Behav; 2004 Feb; 77(2):291-302. PubMed ID: 14751457
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.
Ralph-Williams RJ; Lehmann-Masten V; Otero-Corchon V; Low MJ; Geyer MA
J Neurosci; 2002 Nov; 22(21):9604-11. PubMed ID: 12417685
[TBL] [Abstract][Full Text] [Related]
29. Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats.
Culm KE; Hammer RP
J Pharmacol Exp Ther; 2004 Feb; 308(2):487-94. PubMed ID: 14593083
[TBL] [Abstract][Full Text] [Related]
30. Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.
Sotoyama H; Namba H; Takei N; Nawa H
Psychopharmacology (Berl); 2007 Apr; 191(3):783-92. PubMed ID: 17096084
[TBL] [Abstract][Full Text] [Related]
31. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
[TBL] [Abstract][Full Text] [Related]
32. Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains.
Swerdlow NR; Hines SR; Herrera SD; Weber M; Breier MR
Pharmacol Biochem Behav; 2013 May; 106():128-31. PubMed ID: 23567203
[TBL] [Abstract][Full Text] [Related]
33. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
Swerdlow NR; Geyer MA; Shoemaker JM; Light GA; Braff DL; Stevens KE; Sharp R; Breier M; Neary A; Auerbach PP
Neuropsychopharmacology; 2006 Mar; 31(3):506-15. PubMed ID: 16123772
[TBL] [Abstract][Full Text] [Related]
34. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
35. Removal of short-term isolation stress differentially influences prepulse inhibition in APO-SUS and APO-UNSUS rats.
Sontag TA; Cools AR; Ellenbroek BA
Behav Brain Res; 2003 May; 141(2):171-5. PubMed ID: 12742253
[TBL] [Abstract][Full Text] [Related]
36. Amphetamine effects on startle gating in normal women and female rats.
Talledo JA; Sutherland Owens AN; Schortinghuis T; Swerdlow NR
Psychopharmacology (Berl); 2009 May; 204(1):165-75. PubMed ID: 19148623
[TBL] [Abstract][Full Text] [Related]
37. Pro-dopamine effects of neurotensin on sensorimotor gating deficits.
Feifel D; Reza TL; Robeck SL
Peptides; 1997; 18(9):1457-60. PubMed ID: 9392852
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine.
Weber M; Breier M; Ko D; Thangaraj N; Marzan DE; Swerdlow NR
Psychopharmacology (Berl); 2009 May; 203(4):723-35. PubMed ID: 19066855
[TBL] [Abstract][Full Text] [Related]
40. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
